207 related articles for article (PubMed ID: 17952675)
1. Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions.
Quattrocchi CC; Piciucchi S; Sammarra M; Santini D; Vincenzi B; Tonini G; Grasso RF; Zobel BB
Radiol Med; 2007 Oct; 112(7):1049-59. PubMed ID: 17952675
[TBL] [Abstract][Full Text] [Related]
2. Computed microtomography of bone specimens for rapid analysis of bone changes associated with malignancy.
Chappard D; Libouban H; Legrand E; Ifrah N; Masson C; Baslé MF; Audran M
Anat Rec (Hoboken); 2010 Jul; 293(7):1125-33. PubMed ID: 20583257
[TBL] [Abstract][Full Text] [Related]
3. Tracking the Progression of Osteolytic and Osteosclerotic Lesions in Mice Using Serial In Vivo μCT: Applications to the Assessment of Bisphosphonate Treatment Efficacy.
Campbell GM; Tower RJ; Damm T; Kneissl P; Rambow AC; Schem C; Tiwari S; Glüer CC
J Bone Miner Res; 2018 Mar; 33(3):410-418. PubMed ID: 29044710
[TBL] [Abstract][Full Text] [Related]
4. Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer.
Du Y; Cullum I; Illidge TM; Ell PJ
J Clin Oncol; 2007 Aug; 25(23):3440-7. PubMed ID: 17592153
[TBL] [Abstract][Full Text] [Related]
5. Bone density as a marker for local response to radiotherapy of spinal bone metastases in women with breast cancer: a retrospective analysis.
Foerster R; Eisele C; Bruckner T; Bostel T; Schlampp I; Wolf R; Debus J; Rief H
Radiat Oncol; 2015 Mar; 10():62. PubMed ID: 25884703
[TBL] [Abstract][Full Text] [Related]
6. [Imaging of osteosclerotic metastases].
Feydy A; Carlier R; Vallée C; Mompoint D; Chevallier A; Engerand S; Bhavsar P; Ollivier L
J Radiol; 1995 Sep; 76(9):561-72. PubMed ID: 7473396
[TBL] [Abstract][Full Text] [Related]
7. Role of bone scan in addition to CT in patients with breast cancer selected for systemic staging.
McCartan DP; Prichard RS; MacDermott RJ; Rothwell J; Geraghty J; Evoy D; Quinn CM; Skehan SJ; O'Doherty A; McDermott EW
Br J Surg; 2016 Jun; 103(7):839-44. PubMed ID: 27004443
[TBL] [Abstract][Full Text] [Related]
8. Appearance of untreated bone metastases from breast cancer on FDG PET/CT: importance of histologic subtype.
Dashevsky BZ; Goldman DA; Parsons M; Gönen M; Corben AD; Jochelson MS; Hudis CA; Morrow M; Ulaner GA
Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1666-1673. PubMed ID: 25971426
[TBL] [Abstract][Full Text] [Related]
9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D deficiency promotes growth of MCF-7 human breast cancer in a rodent model of osteosclerotic bone metastasis.
Ooi LL; Zheng Y; Zhou H; Trivedi T; Conigrave AD; Seibel MJ; Dunstan CR
Bone; 2010 Oct; 47(4):795-803. PubMed ID: 20638491
[TBL] [Abstract][Full Text] [Related]
11. A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid.
Quattrocchi CC; Santini D; Dell'aia P; Piciucchi S; Leoncini E; Vincenzi B; Grasso RF; Tonini G; Zobel BB
Skeletal Radiol; 2007 Dec; 36(12):1121-7. PubMed ID: 17912514
[TBL] [Abstract][Full Text] [Related]
12. Lobular breast carcinoma: a case of rare possible 18F-FDG PET/CT and bone scan false negative.
Maffione AM; Lisato LC; Rasi A; Marzola MC; Colletti PM; Rubello D
Clin Nucl Med; 2015 Feb; 40(2):e134-6. PubMed ID: 24999681
[TBL] [Abstract][Full Text] [Related]
13. Detection of bone metastases in breast cancer patients in the PET/CT era: Do we still need the bone scan?
Caglar M; Kupik O; Karabulut E; Høilund-Carlsen PF
Rev Esp Med Nucl Imagen Mol; 2016; 35(1):3-11. PubMed ID: 26514321
[TBL] [Abstract][Full Text] [Related]
14. Gastric and Bone Metastases Arising from Invasive Lobular Carcinoma With Ductal Carcinoma Occurring in one Breast Synchronously.
Namikawa T; Yokota K; Maeda H; Kitagawa H; Tamura M; Satake H; Sugimoto T; Kobayashi M; Hanazaki K; Seo S
Anticancer Res; 2023 Aug; 43(8):3701-3707. PubMed ID: 37500131
[TBL] [Abstract][Full Text] [Related]
15. Automated CT-based analysis to detect changes in the prevalence of lytic bone metastases from breast cancer.
Skrinskas T; Clemons M; Freedman O; Weller I; Whyne CM
Clin Exp Metastasis; 2009; 26(2):97-103. PubMed ID: 18941910
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonates for breast cancer.
Pavlakis N; Schmidt R; Stockler M
Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
[TBL] [Abstract][Full Text] [Related]
17. Osteoblastic metastases from breast carcinoma with false-negative bone scan.
Munk PL; Poon PY; O'Connell JX; Janzen D; Coupland D; Kwong JS; Gelmon K; Worsley D
Skeletal Radiol; 1997 Jul; 26(7):434-7. PubMed ID: 9259104
[TBL] [Abstract][Full Text] [Related]
18. Bone metastases in patients with metastatic breast cancer: morphologic and metabolic monitoring of response to systemic therapy with integrated PET/CT.
Tateishi U; Gamez C; Dawood S; Yeung HW; Cristofanilli M; Macapinlac HA
Radiology; 2008 Apr; 247(1):189-96. PubMed ID: 18372468
[TBL] [Abstract][Full Text] [Related]
19. Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma.
Hogan MP; Goldman DA; Dashevsky B; Riedl CC; Gönen M; Osborne JR; Jochelson M; Hudis C; Morrow M; Ulaner GA
J Nucl Med; 2015 Nov; 56(11):1674-80. PubMed ID: 26294295
[TBL] [Abstract][Full Text] [Related]
20. Early osteosclerotic changes predict chemotherapy response in non-small-cell lung cancer patients with bone metastases.
Rong D; Mao Y; Yang Q; Xu S; Zhao Q; Zhang R
Eur Radiol; 2018 Oct; 28(10):4362-4369. PubMed ID: 29651766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
